FDA worried drug was risky; now reports of deaths spark concern
CNN

Doctors and other experts tell CNN they worried that a new drug, Nuplazid, aimed at treating Parkinson's disease patients with hallucinations was approved too quickly. Now hundreds of reports of deaths are raising more red flags. Read the full story